News and Trends 24 Mar 2025 First-ever RIPTAC enters clinic: all you need to know about this new cancer approach The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics. March 24, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Mar 2025 Cancer vaccines: 11 biotechs to keep an eye out for As various biotechs across the world specialize in the production of cancer vaccines, here are 11 companies making progress in the field. March 18, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Mar 2025 Nine biotechs thriving in Seattle in 2025 In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large. March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 12 Mar 2025 Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field. March 12, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Feb 2025 Seven biotech spinouts to watch out for in 2025 Here are seven biotech spinouts to keep an eye out for this year that specialize in a number of therapeutic areas. February 25, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 24 Feb 2025 Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree? This year has seen Eli Lilly sign several licensing deals to bolster its position across a range of therapeutic areas amid growing drug revenues. February 24, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Feb 2025 T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments T cell engagers represent a novel approach to tuning the immune system to target and kill tumor cells, expanding treatment options for cancer. February 18, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 14 Feb 2025Reversing cancer mechanisms to fight back against solid tumors This week, we have a conversation with Catalym’s Eugen Leo about Visugromab is a monoclonal antibody that neutralizes the tumor-derived growth differentiation factor-15. February 14, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 4 Feb 2025 World Cancer Day: trends in cancer therapeutics to look forward to in 2025 As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer care in 2025. February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Feb 2025 Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach February 4, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 31 Jan 2025Can tumor activated therapy kill solid tumors? Solid tumors are a big challenge. However, a new approach might provide the answer – tumor-activated Therapy. We discuss this with Seekyo Therapeutics’ CEO, Oury Chetboun January 31, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 29 Jan 2025 Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic Discover the treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to treat. January 29, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email